The treatment of Basal Joint Arthritis & Senile Dementia with vitamins

Basal Joint Arthritis and Senile Dementia: Mitamins custom make quality formulas for the treatment of Basal Joint Arthritis & Senile Dementia with vitamins. A Basal Joint Arthritis & Senile Dementia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Basal Joint Arthritis and Senile Dementia

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin E
    200
    IU
    667%
    Thiamin
    50
    mg
    3333%
    Vitamin B12
    125
    mcg
    2083%
    Potassium
    100
    mg
    3%
    Flax Seed Powder
    50
    mg
    *
    Omega - 3 Fatty Acids
    100
    mg
    *
    Chondroitin Sulfate
    200
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
  • Amount Per Serving
    % DV
    Feverfew Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    American Ginseng Extract
    100
    mg
    *
    Licorice Extract
    250
    mg
    *
    Acetyl L-Carnitine
    250
    mg
    *
    Phosphatidylserine
    100
    mg
    *
    Ginger Extract
    100
    mg
    *
    White Willow Extract
    60
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Basal Joint Arthritis and Senile Dementia
Monthly Cost: $50.06
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Basal Joint Arthritis and Senile Dementia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Iomai Launches Phase 1/2 Safety Study Of Dose-Sparing Patch For Use With Pandemic Influenza Vaccine
Iomai Corporation (Nasdaq: IOMI) announced that it has begun dosing in a Phase 1/2 study that will assess the safety and dose-sparing capability of the company's immunostimulant patch when used in combination with an injected H5N1 influenza vaccine. The Iomai patch, which contains a powerful immune-stimulating adjuvant, is used in conjunction with an injected influenza vaccine and may generate an immune response with small amounts of vaccine antigen.
ZymoGenetics And Merck Serono Receive FDA Special Protocol Assessment For Atacicept Pivotal Study In Lupus Nephritis
ZymoGenetics, Inc. (Nasdaq: ZGEN) announced that, together with its collaborator Merck Serono, it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) to conduct a pivotal clinical trial with the investigational new drug atacicept for the treatment of patients with lupus nephritis. This is one of two clinical studies intended to form part of the application for marketing authorization.
This information concerning the support of Basal Joint Arthritis and Senile Dementia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Arthritis & Gout  Basal Joint Arthritis  Basal Joint Arthritis and Senile Dementia
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments